Quick Answer
LIGAND PHARMACEUTICALS INC reported Total Assets of $1.56 billion for fiscal year 2025.
LIGAND PHARMACEUTICALS INC Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $1.56B | +65.7% |
| 2024 | $941.77M | +19.6% |
| 2023 | $787.22M | +3.2% |
| 2022 | $762.67M | -41.2% |
| 2021 | $1.30B | -4.7% |
| 2020 | $1.36B | -8.9% |
| 2019 | $1.49B | +18.6% |
| 2018 | $1.26B | +87.9% |
| 2017 | $671.02M | +11.5% |
| 2016 | $601.59M | +19.6% |
| 2015 | $503.06M | +95.0% |
| 2014 | $258.03M | +146.4% |
| 2013 | $104.71M | +0.4% |
| 2012 | $104.26M | -13.5% |
| 2011 | $120.58M | +59.6% |
| 2010 | $75.56M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.48B | +54.7% | +55.7% |
| June 30, 2025 | $948.60M | +9.5% | +4.8% |
| March 31, 2025 | $905.43M | -0.9% | -3.9% |
| December 31, 2024 | $941.77M | +19.6% | -1.4% |
| September 30, 2024 | $954.87M | +24.1% | +10.2% |
| June 30, 2024 | $866.40M | +14.3% | -5.2% |
| March 31, 2024 | $913.87M | +12.7% | +16.1% |
| December 31, 2023 | $787.22M | +3.2% | +2.3% |
- LIGAND PHARMACEUTICALS INC showed an increase of +65.7% in Total Assets compared to the prior fiscal year.
- Over the 2010–2025 period, LIGAND PHARMACEUTICALS INC’s total assets has grown by 1965.5% (from $75.56 million to $1.56 billion).
- The most recent figure is from LIGAND PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: